Kaplan-Meier graphs for breast cancer incidence in the tamoxifen arm
By A Mystery Man Writer
Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine
Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine
Kaplan-Meier graphs for breast cancer incidence in the tamoxifen arm
Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine
Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
Ivana SESTAK, Associate Professor in Medical Statistics, Queen Mary, University of London, London, QMUL, Wolfson Institute of Preventive Medicine
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial
PDF) Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial